nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—ABCG2—Fluorouracil—head and neck cancer	0.133	0.207	CbGbCtD
Hydrocortisone—ABCG2—Docetaxel—head and neck cancer	0.101	0.158	CbGbCtD
Hydrocortisone—CYP3A7—Docetaxel—head and neck cancer	0.0749	0.117	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0749	0.117	CbGbCtD
Hydrocortisone—CYP2C8—Fluorouracil—head and neck cancer	0.0707	0.11	CbGbCtD
Hydrocortisone—CYP3A5—Docetaxel—head and neck cancer	0.0562	0.0877	CbGbCtD
Hydrocortisone—ABCB1—Vinblastine—head and neck cancer	0.0443	0.0693	CbGbCtD
Hydrocortisone—ABCB1—Docetaxel—head and neck cancer	0.0365	0.0571	CbGbCtD
Hydrocortisone—CYP3A4—Vinblastine—head and neck cancer	0.0266	0.0415	CbGbCtD
Hydrocortisone—CYP3A4—Docetaxel—head and neck cancer	0.0219	0.0342	CbGbCtD
Hydrocortisone—Erythema facial—Hydroxyurea—head and neck cancer	0.0114	0.0518	CcSEcCtD
Hydrocortisone—Application site burn—Fluorouracil—head and neck cancer	0.00718	0.0325	CcSEcCtD
Hydrocortisone—Skin atrophy—Hydroxyurea—head and neck cancer	0.00692	0.0313	CcSEcCtD
Hydrocortisone—Atrophy—Hydroxyurea—head and neck cancer	0.00641	0.029	CcSEcCtD
Hydrocortisone—Telangiectasia—Fluorouracil—head and neck cancer	0.00638	0.0289	CcSEcCtD
Hydrocortisone—Allergic contact dermatitis—Fluorouracil—head and neck cancer	0.00431	0.0195	CcSEcCtD
Hydrocortisone—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00351	0.0159	CcSEcCtD
Hydrocortisone—Skin irritation—Fluorouracil—head and neck cancer	0.00348	0.0157	CcSEcCtD
Hydrocortisone—Peptic ulcer—Vinblastine—head and neck cancer	0.00343	0.0155	CcSEcCtD
Hydrocortisone—Application site pain—Fluorouracil—head and neck cancer	0.00342	0.0155	CcSEcCtD
Hydrocortisone—Eruption—Hydroxyurea—head and neck cancer	0.0034	0.0154	CcSEcCtD
Hydrocortisone—Application site reaction—Fluorouracil—head and neck cancer	0.00321	0.0145	CcSEcCtD
Hydrocortisone—Neuritis—Vinblastine—head and neck cancer	0.00307	0.0139	CcSEcCtD
Hydrocortisone—ANXA1—exocrine gland—head and neck cancer	0.00299	0.0959	CbGeAlD
Hydrocortisone—Oesophageal ulcer—Docetaxel—head and neck cancer	0.00298	0.0135	CcSEcCtD
Hydrocortisone—ANXA1—hair follicle—head and neck cancer	0.00285	0.0914	CbGeAlD
Hydrocortisone—Rectal haemorrhage—Vinblastine—head and neck cancer	0.00254	0.0115	CcSEcCtD
Hydrocortisone—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00253	0.0114	CcSEcCtD
Hydrocortisone—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00238	0.0108	CcSEcCtD
Hydrocortisone—Prurigo—Docetaxel—head and neck cancer	0.00235	0.0106	CcSEcCtD
Hydrocortisone—ANXA1—mouth—head and neck cancer	0.00224	0.0717	CbGeAlD
Hydrocortisone—Skin exfoliation—Hydroxyurea—head and neck cancer	0.002	0.00903	CcSEcCtD
Hydrocortisone—Menstruation irregular—Docetaxel—head and neck cancer	0.00196	0.00887	CcSEcCtD
Hydrocortisone—Necrosis—Fluorouracil—head and neck cancer	0.00192	0.00867	CcSEcCtD
Hydrocortisone—ANXA1—neck—head and neck cancer	0.00191	0.0613	CbGeAlD
Hydrocortisone—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.0019	0.00859	CcSEcCtD
Hydrocortisone—Tingling sensation—Fluorouracil—head and neck cancer	0.00187	0.00847	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00186	0.00842	CcSEcCtD
Hydrocortisone—Stinging—Fluorouracil—head and neck cancer	0.00186	0.0084	CcSEcCtD
Hydrocortisone—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00183	0.00826	CcSEcCtD
Hydrocortisone—Eruption—Docetaxel—head and neck cancer	0.00177	0.00799	CcSEcCtD
Hydrocortisone—Embolism—Docetaxel—head and neck cancer	0.00169	0.00765	CcSEcCtD
Hydrocortisone—Redness—Docetaxel—head and neck cancer	0.00161	0.00728	CcSEcCtD
Hydrocortisone—Leukocytosis—Fluorouracil—head and neck cancer	0.0016	0.00724	CcSEcCtD
Hydrocortisone—ANXA1—parotid gland—head and neck cancer	0.00156	0.0499	CbGeAlD
Hydrocortisone—Inflammation—Fluorouracil—head and neck cancer	0.00155	0.00702	CcSEcCtD
Hydrocortisone—ANXA1—saliva-secreting gland—head and neck cancer	0.00149	0.0478	CbGeAlD
Hydrocortisone—Dermatitis contact—Fluorouracil—head and neck cancer	0.00149	0.00673	CcSEcCtD
Hydrocortisone—Neuritis—Docetaxel—head and neck cancer	0.00145	0.00658	CcSEcCtD
Hydrocortisone—Necrosis—Docetaxel—head and neck cancer	0.00138	0.00626	CcSEcCtD
Hydrocortisone—Oesophagitis—Fluorouracil—head and neck cancer	0.00137	0.00622	CcSEcCtD
Hydrocortisone—ANXA1—connective tissue—head and neck cancer	0.00137	0.0439	CbGeAlD
Hydrocortisone—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00137	0.00619	CcSEcCtD
Hydrocortisone—ANXA1—epithelium—head and neck cancer	0.0013	0.0417	CbGeAlD
Hydrocortisone—Euphoric mood—Fluorouracil—head and neck cancer	0.00129	0.00585	CcSEcCtD
Hydrocortisone—Pancreatitis—Hydroxyurea—head and neck cancer	0.00129	0.00582	CcSEcCtD
Hydrocortisone—SHBG—neck—head and neck cancer	0.00128	0.041	CbGeAlD
Hydrocortisone—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00126	0.00572	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00126	0.00571	CcSEcCtD
Hydrocortisone—Myocardial infarction—Vinblastine—head and neck cancer	0.00126	0.00568	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00126	0.00568	CcSEcCtD
Hydrocortisone—Amenorrhoea—Docetaxel—head and neck cancer	0.00124	0.00559	CcSEcCtD
Hydrocortisone—Weight increased—Hydroxyurea—head and neck cancer	0.00119	0.0054	CcSEcCtD
Hydrocortisone—Infestation NOS—Hydroxyurea—head and neck cancer	0.00117	0.00529	CcSEcCtD
Hydrocortisone—Infestation—Hydroxyurea—head and neck cancer	0.00117	0.00529	CcSEcCtD
Hydrocortisone—Haemoglobin—Vinblastine—head and neck cancer	0.00116	0.00523	CcSEcCtD
Hydrocortisone—ANXA1—trachea—head and neck cancer	0.00115	0.0369	CbGeAlD
Hydrocortisone—Haemorrhage—Vinblastine—head and neck cancer	0.00115	0.00521	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00115	0.00518	CcSEcCtD
Hydrocortisone—Inflammation—Docetaxel—head and neck cancer	0.00112	0.00506	CcSEcCtD
Hydrocortisone—Cardiac failure—Fluorouracil—head and neck cancer	0.00112	0.00506	CcSEcCtD
Hydrocortisone—Lethargy—Fluorouracil—head and neck cancer	0.00111	0.00504	CcSEcCtD
Hydrocortisone—Osteoarthritis—Fluorouracil—head and neck cancer	0.00109	0.00494	CcSEcCtD
Hydrocortisone—Haemoglobin—Hydroxyurea—head and neck cancer	0.00105	0.00477	CcSEcCtD
Hydrocortisone—Haemorrhage—Hydroxyurea—head and neck cancer	0.00105	0.00475	CcSEcCtD
Hydrocortisone—Hallucination—Hydroxyurea—head and neck cancer	0.00104	0.00472	CcSEcCtD
Hydrocortisone—Irritability—Fluorouracil—head and neck cancer	0.00104	0.00471	CcSEcCtD
Hydrocortisone—Cardiac arrest—Fluorouracil—head and neck cancer	0.00104	0.0047	CcSEcCtD
Hydrocortisone—Skin exfoliation—Docetaxel—head and neck cancer	0.00104	0.00469	CcSEcCtD
Hydrocortisone—Fluid retention—Docetaxel—head and neck cancer	0.00103	0.00466	CcSEcCtD
Hydrocortisone—Neuropathy—Docetaxel—head and neck cancer	0.00102	0.00461	CcSEcCtD
Hydrocortisone—ANXA1—lymphoid tissue—head and neck cancer	0.001	0.0321	CbGeAlD
Hydrocortisone—Dry skin—Fluorouracil—head and neck cancer	0.001	0.00453	CcSEcCtD
Hydrocortisone—Oesophagitis—Docetaxel—head and neck cancer	0.000992	0.00449	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Docetaxel—head and neck cancer	0.000966	0.00437	CcSEcCtD
Hydrocortisone—Muscular weakness—Fluorouracil—head and neck cancer	0.000963	0.00436	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Vinblastine—head and neck cancer	0.000929	0.0042	CcSEcCtD
Hydrocortisone—SHBG—connective tissue—head and neck cancer	0.000917	0.0294	CbGeAlD
Hydrocortisone—Erythema—Hydroxyurea—head and neck cancer	0.000914	0.00413	CcSEcCtD
Hydrocortisone—ANXA1—thyroid gland—head and neck cancer	0.000911	0.0292	CbGeAlD
Hydrocortisone—Thrombophlebitis—Docetaxel—head and neck cancer	0.00091	0.00412	CcSEcCtD
Hydrocortisone—Malaise—Vinblastine—head and neck cancer	0.000903	0.00409	CcSEcCtD
Hydrocortisone—Vertigo—Vinblastine—head and neck cancer	0.0009	0.00407	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000877	0.00397	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000869	0.00393	CcSEcCtD
Hydrocortisone—Convulsion—Vinblastine—head and neck cancer	0.000868	0.00393	CcSEcCtD
Hydrocortisone—Hypertension—Vinblastine—head and neck cancer	0.000865	0.00391	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000848	0.00383	CcSEcCtD
Hydrocortisone—Discomfort—Vinblastine—head and neck cancer	0.000843	0.00381	CcSEcCtD
Hydrocortisone—Infestation—Fluorouracil—head and neck cancer	0.000841	0.00381	CcSEcCtD
Hydrocortisone—Infestation NOS—Fluorouracil—head and neck cancer	0.000841	0.00381	CcSEcCtD
Hydrocortisone—CYP11B2—lymph node—head and neck cancer	0.000831	0.0266	CbGeAlD
Hydrocortisone—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00083	0.00375	CcSEcCtD
Hydrocortisone—Myocardial infarction—Fluorouracil—head and neck cancer	0.000825	0.00373	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000825	0.00373	CcSEcCtD
Hydrocortisone—Malaise—Hydroxyurea—head and neck cancer	0.000824	0.00373	CcSEcCtD
Hydrocortisone—ANXA1—head—head and neck cancer	0.000809	0.0259	CbGeAlD
Hydrocortisone—Cardiac failure—Docetaxel—head and neck cancer	0.000808	0.00365	CcSEcCtD
Hydrocortisone—Lethargy—Docetaxel—head and neck cancer	0.000804	0.00364	CcSEcCtD
Hydrocortisone—Convulsion—Hydroxyurea—head and neck cancer	0.000792	0.00358	CcSEcCtD
Hydrocortisone—Anorexia—Vinblastine—head and neck cancer	0.000779	0.00353	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000772	0.00349	CcSEcCtD
Hydrocortisone—Discomfort—Hydroxyurea—head and neck cancer	0.000768	0.00348	CcSEcCtD
Hydrocortisone—Haemoglobin—Fluorouracil—head and neck cancer	0.000759	0.00343	CcSEcCtD
Hydrocortisone—Haemorrhage—Fluorouracil—head and neck cancer	0.000755	0.00342	CcSEcCtD
Hydrocortisone—Oedema—Hydroxyurea—head and neck cancer	0.000746	0.00337	CcSEcCtD
Hydrocortisone—Infection—Hydroxyurea—head and neck cancer	0.000741	0.00335	CcSEcCtD
Hydrocortisone—Paraesthesia—Vinblastine—head and neck cancer	0.000734	0.00332	CcSEcCtD
Hydrocortisone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000731	0.00331	CcSEcCtD
Hydrocortisone—Skin disorder—Hydroxyurea—head and neck cancer	0.000724	0.00328	CcSEcCtD
Hydrocortisone—Dry skin—Docetaxel—head and neck cancer	0.000722	0.00327	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Docetaxel—head and neck cancer	0.00072	0.00326	CcSEcCtD
Hydrocortisone—Anorexia—Hydroxyurea—head and neck cancer	0.000711	0.00322	CcSEcCtD
Hydrocortisone—Decreased appetite—Vinblastine—head and neck cancer	0.000711	0.00322	CcSEcCtD
Hydrocortisone—Pain—Vinblastine—head and neck cancer	0.000699	0.00316	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000695	0.00314	CcSEcCtD
Hydrocortisone—Arrhythmia—Fluorouracil—head and neck cancer	0.000675	0.00305	CcSEcCtD
Hydrocortisone—Feeling abnormal—Vinblastine—head and neck cancer	0.000674	0.00305	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000669	0.00302	CcSEcCtD
Hydrocortisone—NR3C1—neck—head and neck cancer	0.000665	0.0213	CbGeAlD
Hydrocortisone—Erythema—Fluorouracil—head and neck cancer	0.000658	0.00297	CcSEcCtD
Hydrocortisone—Dyspepsia—Hydroxyurea—head and neck cancer	0.000656	0.00297	CcSEcCtD
Hydrocortisone—Decreased appetite—Hydroxyurea—head and neck cancer	0.000648	0.00293	CcSEcCtD
Hydrocortisone—Abdominal pain—Vinblastine—head and neck cancer	0.000646	0.00292	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000644	0.00291	CcSEcCtD
Hydrocortisone—Fatigue—Hydroxyurea—head and neck cancer	0.000643	0.00291	CcSEcCtD
Hydrocortisone—Pain—Hydroxyurea—head and neck cancer	0.000638	0.00288	CcSEcCtD
Hydrocortisone—Weight increased—Docetaxel—head and neck cancer	0.00062	0.0028	CcSEcCtD
Hydrocortisone—Weight decreased—Docetaxel—head and neck cancer	0.000616	0.00279	CcSEcCtD
Hydrocortisone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000614	0.00278	CcSEcCtD
Hydrocortisone—SHBG—thyroid gland—head and neck cancer	0.000609	0.0195	CbGeAlD
Hydrocortisone—Infestation—Docetaxel—head and neck cancer	0.000607	0.00275	CcSEcCtD
Hydrocortisone—Infestation NOS—Docetaxel—head and neck cancer	0.000607	0.00275	CcSEcCtD
Hydrocortisone—Hypersensitivity—Vinblastine—head and neck cancer	0.000602	0.00273	CcSEcCtD
Hydrocortisone—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000599	0.00271	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000595	0.00269	CcSEcCtD
Hydrocortisone—Myocardial infarction—Docetaxel—head and neck cancer	0.000595	0.00269	CcSEcCtD
Hydrocortisone—Body temperature increased—Hydroxyurea—head and neck cancer	0.000589	0.00267	CcSEcCtD
Hydrocortisone—ABCG2—parotid gland—head and neck cancer	0.000588	0.0188	CbGeAlD
Hydrocortisone—Asthenia—Vinblastine—head and neck cancer	0.000587	0.00265	CcSEcCtD
Hydrocortisone—Convulsion—Fluorouracil—head and neck cancer	0.00057	0.00258	CcSEcCtD
Hydrocortisone—ANXA1—lymph node—head and neck cancer	0.000566	0.0181	CbGeAlD
Hydrocortisone—ABCG2—saliva-secreting gland—head and neck cancer	0.000563	0.018	CbGeAlD
Hydrocortisone—Myalgia—Fluorouracil—head and neck cancer	0.00056	0.00253	CcSEcCtD
Hydrocortisone—Diarrhoea—Vinblastine—head and neck cancer	0.000559	0.00253	CcSEcCtD
Hydrocortisone—Discomfort—Fluorouracil—head and neck cancer	0.000553	0.0025	CcSEcCtD
Hydrocortisone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000549	0.00249	CcSEcCtD
Hydrocortisone—Haemoglobin—Docetaxel—head and neck cancer	0.000548	0.00248	CcSEcCtD
Hydrocortisone—Haemorrhage—Docetaxel—head and neck cancer	0.000545	0.00247	CcSEcCtD
Hydrocortisone—NR3C1—parotid gland—head and neck cancer	0.000542	0.0173	CbGeAlD
Hydrocortisone—Dizziness—Vinblastine—head and neck cancer	0.000541	0.00245	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000537	0.00243	CcSEcCtD
Hydrocortisone—Oedema—Fluorouracil—head and neck cancer	0.000537	0.00243	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Docetaxel—head and neck cancer	0.000536	0.00242	CcSEcCtD
Hydrocortisone—Asthenia—Hydroxyurea—head and neck cancer	0.000535	0.00242	CcSEcCtD
Hydrocortisone—Infection—Fluorouracil—head and neck cancer	0.000533	0.00241	CcSEcCtD
Hydrocortisone—Nervous system disorder—Fluorouracil—head and neck cancer	0.000526	0.00238	CcSEcCtD
Hydrocortisone—Tachycardia—Fluorouracil—head and neck cancer	0.000524	0.00237	CcSEcCtD
Hydrocortisone—Vomiting—Vinblastine—head and neck cancer	0.00052	0.00235	CcSEcCtD
Hydrocortisone—NR3C1—saliva-secreting gland—head and neck cancer	0.000519	0.0166	CbGeAlD
Hydrocortisone—Headache—Vinblastine—head and neck cancer	0.000512	0.00232	CcSEcCtD
Hydrocortisone—Anorexia—Fluorouracil—head and neck cancer	0.000512	0.00231	CcSEcCtD
Hydrocortisone—Drospirenone—PTGS2—head and neck cancer	0.00051	0.224	CrCbGaD
Hydrocortisone—Diarrhoea—Hydroxyurea—head and neck cancer	0.00051	0.00231	CcSEcCtD
Hydrocortisone—Eye disorder—Docetaxel—head and neck cancer	0.00051	0.00231	CcSEcCtD
Hydrocortisone—Hypotension—Fluorouracil—head and neck cancer	0.000501	0.00227	CcSEcCtD
Hydrocortisone—Dizziness—Hydroxyurea—head and neck cancer	0.000493	0.00223	CcSEcCtD
Hydrocortisone—Immune system disorder—Docetaxel—head and neck cancer	0.000492	0.00223	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000489	0.00221	CcSEcCtD
Hydrocortisone—Arrhythmia—Docetaxel—head and neck cancer	0.000487	0.0022	CcSEcCtD
Hydrocortisone—Nausea—Vinblastine—head and neck cancer	0.000486	0.0022	CcSEcCtD
Hydrocortisone—Insomnia—Fluorouracil—head and neck cancer	0.000485	0.0022	CcSEcCtD
Hydrocortisone—Paraesthesia—Fluorouracil—head and neck cancer	0.000482	0.00218	CcSEcCtD
Hydrocortisone—Mental disorder—Docetaxel—head and neck cancer	0.000478	0.00216	CcSEcCtD
Hydrocortisone—NR3C1—connective tissue—head and neck cancer	0.000477	0.0153	CbGeAlD
Hydrocortisone—Erythema—Docetaxel—head and neck cancer	0.000475	0.00215	CcSEcCtD
Hydrocortisone—Malnutrition—Docetaxel—head and neck cancer	0.000475	0.00215	CcSEcCtD
Hydrocortisone—Vomiting—Hydroxyurea—head and neck cancer	0.000474	0.00214	CcSEcCtD
Hydrocortisone—Dyspepsia—Fluorouracil—head and neck cancer	0.000472	0.00214	CcSEcCtD
Hydrocortisone—Rash—Hydroxyurea—head and neck cancer	0.00047	0.00213	CcSEcCtD
Hydrocortisone—Dermatitis—Hydroxyurea—head and neck cancer	0.00047	0.00212	CcSEcCtD
Hydrocortisone—Headache—Hydroxyurea—head and neck cancer	0.000467	0.00211	CcSEcCtD
Hydrocortisone—Decreased appetite—Fluorouracil—head and neck cancer	0.000467	0.00211	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000463	0.0021	CcSEcCtD
Hydrocortisone—Pain—Fluorouracil—head and neck cancer	0.000459	0.00208	CcSEcCtD
Hydrocortisone—NR3C1—epithelium—head and neck cancer	0.000453	0.0145	CbGeAlD
Hydrocortisone—SLCO1A2—head—head and neck cancer	0.000449	0.0144	CbGeAlD
Hydrocortisone—Nausea—Hydroxyurea—head and neck cancer	0.000443	0.002	CcSEcCtD
Hydrocortisone—Feeling abnormal—Fluorouracil—head and neck cancer	0.000442	0.002	CcSEcCtD
Hydrocortisone—Urticaria—Fluorouracil—head and neck cancer	0.000426	0.00193	CcSEcCtD
Hydrocortisone—Syncope—Docetaxel—head and neck cancer	0.000426	0.00193	CcSEcCtD
Hydrocortisone—Body temperature increased—Fluorouracil—head and neck cancer	0.000424	0.00192	CcSEcCtD
Hydrocortisone—Loss of consciousness—Docetaxel—head and neck cancer	0.000417	0.00189	CcSEcCtD
Hydrocortisone—Convulsion—Docetaxel—head and neck cancer	0.000411	0.00186	CcSEcCtD
Hydrocortisone—Hypertension—Docetaxel—head and neck cancer	0.00041	0.00185	CcSEcCtD
Hydrocortisone—Myalgia—Docetaxel—head and neck cancer	0.000404	0.00183	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000401	0.00182	CcSEcCtD
Hydrocortisone—NR3C1—trachea—head and neck cancer	0.0004	0.0128	CbGeAlD
Hydrocortisone—Hypersensitivity—Fluorouracil—head and neck cancer	0.000395	0.00179	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Docetaxel—head and neck cancer	0.000387	0.00175	CcSEcCtD
Hydrocortisone—Oedema—Docetaxel—head and neck cancer	0.000387	0.00175	CcSEcCtD
Hydrocortisone—Infection—Docetaxel—head and neck cancer	0.000385	0.00174	CcSEcCtD
Hydrocortisone—Shock—Docetaxel—head and neck cancer	0.000381	0.00172	CcSEcCtD
Hydrocortisone—Nervous system disorder—Docetaxel—head and neck cancer	0.00038	0.00172	CcSEcCtD
Hydrocortisone—Pruritus—Fluorouracil—head and neck cancer	0.00038	0.00172	CcSEcCtD
Hydrocortisone—Tachycardia—Docetaxel—head and neck cancer	0.000378	0.00171	CcSEcCtD
Hydrocortisone—Triamcinolone—PTGS2—head and neck cancer	0.000377	0.166	CrCbGaD
Hydrocortisone—Skin disorder—Docetaxel—head and neck cancer	0.000376	0.0017	CcSEcCtD
Hydrocortisone—Anorexia—Docetaxel—head and neck cancer	0.000369	0.00167	CcSEcCtD
Hydrocortisone—Diarrhoea—Fluorouracil—head and neck cancer	0.000367	0.00166	CcSEcCtD
Hydrocortisone—Hypotension—Docetaxel—head and neck cancer	0.000362	0.00164	CcSEcCtD
Hydrocortisone—Dizziness—Fluorouracil—head and neck cancer	0.000355	0.00161	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000353	0.0016	CcSEcCtD
Hydrocortisone—Insomnia—Docetaxel—head and neck cancer	0.00035	0.00158	CcSEcCtD
Hydrocortisone—NR3C1—lymphoid tissue—head and neck cancer	0.000349	0.0112	CbGeAlD
Hydrocortisone—Paraesthesia—Docetaxel—head and neck cancer	0.000348	0.00157	CcSEcCtD
Hydrocortisone—ABCG2—thyroid gland—head and neck cancer	0.000344	0.011	CbGeAlD
Hydrocortisone—Vomiting—Fluorouracil—head and neck cancer	0.000341	0.00154	CcSEcCtD
Hydrocortisone—Dyspepsia—Docetaxel—head and neck cancer	0.000341	0.00154	CcSEcCtD
Hydrocortisone—Rash—Fluorouracil—head and neck cancer	0.000338	0.00153	CcSEcCtD
Hydrocortisone—Dermatitis—Fluorouracil—head and neck cancer	0.000338	0.00153	CcSEcCtD
Hydrocortisone—Decreased appetite—Docetaxel—head and neck cancer	0.000337	0.00152	CcSEcCtD
Hydrocortisone—Headache—Fluorouracil—head and neck cancer	0.000336	0.00152	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000334	0.00151	CcSEcCtD
Hydrocortisone—Fatigue—Docetaxel—head and neck cancer	0.000334	0.00151	CcSEcCtD
Hydrocortisone—Pain—Docetaxel—head and neck cancer	0.000331	0.0015	CcSEcCtD
Hydrocortisone—Feeling abnormal—Docetaxel—head and neck cancer	0.000319	0.00144	CcSEcCtD
Hydrocortisone—Nausea—Fluorouracil—head and neck cancer	0.000319	0.00144	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000317	0.00143	CcSEcCtD
Hydrocortisone—NR3C1—thyroid gland—head and neck cancer	0.000317	0.0101	CbGeAlD
Hydrocortisone—Progesterone—CYP1A1—head and neck cancer	0.000315	0.138	CrCbGaD
Hydrocortisone—Betamethasone—PTGS2—head and neck cancer	0.000309	0.136	CrCbGaD
Hydrocortisone—Abdominal pain—Docetaxel—head and neck cancer	0.000306	0.00139	CcSEcCtD
Hydrocortisone—Body temperature increased—Docetaxel—head and neck cancer	0.000306	0.00139	CcSEcCtD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—MAPK3—head and neck cancer	0.000298	0.00283	CbGpPWpGaD
Hydrocortisone—Testosterone—CYP1A1—head and neck cancer	0.000297	0.131	CrCbGaD
Hydrocortisone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000292	0.00277	CbGpPWpGaD
Hydrocortisone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000288	0.00273	CbGpPWpGaD
Hydrocortisone—Dexamethasone—CYP1A1—head and neck cancer	0.000288	0.126	CrCbGaD
Hydrocortisone—Hypersensitivity—Docetaxel—head and neck cancer	0.000285	0.00129	CcSEcCtD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—MAPK1—head and neck cancer	0.000284	0.00269	CbGpPWpGaD
Hydrocortisone—NR3C1—head—head and neck cancer	0.000281	0.00899	CbGeAlD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000278	0.00264	CbGpPWpGaD
Hydrocortisone—Asthenia—Docetaxel—head and neck cancer	0.000278	0.00126	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000278	0.00263	CbGpPWpGaD
Hydrocortisone—Pruritus—Docetaxel—head and neck cancer	0.000274	0.00124	CcSEcCtD
Hydrocortisone—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000273	0.00259	CbGpPWpGaD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000269	0.00255	CbGpPWpGaD
Hydrocortisone—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000268	0.00255	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Docetaxel—head and neck cancer	0.000265	0.0012	CcSEcCtD
Hydrocortisone—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000265	0.00251	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000263	0.00249	CbGpPWpGaD
Hydrocortisone—Dizziness—Docetaxel—head and neck cancer	0.000256	0.00116	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000253	0.0024	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000252	0.00239	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.00025	0.00237	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.00025	0.00237	CbGpPWpGaD
Hydrocortisone—Vomiting—Docetaxel—head and neck cancer	0.000246	0.00111	CcSEcCtD
Hydrocortisone—Rash—Docetaxel—head and neck cancer	0.000244	0.0011	CcSEcCtD
Hydrocortisone—Dermatitis—Docetaxel—head and neck cancer	0.000244	0.0011	CcSEcCtD
Hydrocortisone—Headache—Docetaxel—head and neck cancer	0.000243	0.0011	CcSEcCtD
Hydrocortisone—ABCB1—epithelium—head and neck cancer	0.000242	0.00776	CbGeAlD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000239	0.00227	CbGpPWpGaD
Hydrocortisone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000237	0.00224	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KISS1—head and neck cancer	0.000232	0.0022	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.000231	0.00219	CbGpPWpGaD
Hydrocortisone—Nausea—Docetaxel—head and neck cancer	0.00023	0.00104	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000227	0.00216	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000227	0.00216	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—UROD—head and neck cancer	0.000225	0.00213	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000225	0.00213	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000221	0.00209	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000217	0.00206	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000217	0.00206	CbGpPWpGaD
Hydrocortisone—ABCB1—trachea—head and neck cancer	0.000214	0.00686	CbGeAlD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000214	0.00203	CbGpPWpGaD
Hydrocortisone—ABCG2—lymph node—head and neck cancer	0.000213	0.00684	CbGeAlD
Hydrocortisone—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	0.000212	0.00201	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.00021	0.00199	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000209	0.00198	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000204	0.00194	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.000203	0.00193	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—AKT1—head and neck cancer	0.000201	0.00191	CbGpPWpGaD
Hydrocortisone—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000201	0.0019	CbGpPWpGaD
Hydrocortisone—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	0.000201	0.0019	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.0002	0.00189	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000198	0.00188	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000197	0.00187	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000197	0.00187	CbGpPWpGaD
Hydrocortisone—NR3C1—lymph node—head and neck cancer	0.000197	0.0063	CbGeAlD
Hydrocortisone—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000194	0.00184	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—GRP—head and neck cancer	0.000191	0.00181	CbGpPWpGaD
Hydrocortisone—ABCB1—lymphoid tissue—head and neck cancer	0.000187	0.00597	CbGeAlD
Hydrocortisone—ANXA1—Signaling Pathways—STAT6—head and neck cancer	0.000185	0.00176	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000184	0.00174	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000183	0.00173	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.000182	0.00172	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000182	0.00172	CbGpPWpGaD
Hydrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000181	0.00172	CbGpPWpGaD
Hydrocortisone—Dexamethasone—PTGS2—head and neck cancer	0.00018	0.079	CrCbGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000179	0.0017	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—UROD—head and neck cancer	0.000178	0.00169	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000177	0.00168	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—UROD—head and neck cancer	0.000177	0.00167	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000175	0.00166	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—NAT2—head and neck cancer	0.000173	0.00164	CbGpPWpGaD
Hydrocortisone—ABCB1—thyroid gland—head and neck cancer	0.000169	0.00543	CbGeAlD
Hydrocortisone—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000165	0.00157	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—YAP1—head and neck cancer	0.000164	0.00155	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000163	0.00155	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000158	0.0015	CbGpPWpGaD
Hydrocortisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000157	0.00149	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000157	0.00149	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.000155	0.00147	CbGpPWpGaD
Hydrocortisone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000155	0.00147	CbGpPWpGaD
Hydrocortisone—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000153	0.00145	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—DPYD—head and neck cancer	0.000152	0.00144	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000151	0.00143	CbGpPWpGaD
Hydrocortisone—ABCB1—head—head and neck cancer	0.00015	0.00481	CbGeAlD
Hydrocortisone—CYP11B1—Metabolism—NAT2—head and neck cancer	0.000149	0.00141	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000149	0.00141	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.000148	0.0014	CbGpPWpGaD
Hydrocortisone—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000145	0.00138	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000144	0.00137	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—YAP1—head and neck cancer	0.000144	0.00136	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000143	0.00136	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000142	0.00135	CbGpPWpGaD
Hydrocortisone—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000133	0.00126	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000131	0.00124	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—DPYD—head and neck cancer	0.000131	0.00124	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.00013	0.00124	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.00013	0.00124	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—UROD—head and neck cancer	0.000128	0.00121	CbGpPWpGaD
Hydrocortisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000127	0.0012	CbGpPWpGaD
Hydrocortisone—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000126	0.00119	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—YAP1—head and neck cancer	0.000124	0.00118	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000124	0.00118	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—STAT3—head and neck cancer	0.000118	0.00112	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.000112	0.00107	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000111	0.00106	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—UROD—head and neck cancer	0.000111	0.00105	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.00011	0.00105	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.00011	0.00105	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000108	0.00103	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000108	0.00102	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000107	0.00102	CbGpPWpGaD
Hydrocortisone—ABCB1—lymph node—head and neck cancer	0.000105	0.00337	CbGeAlD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000103	0.000979	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.92e-05	0.000941	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.82e-05	0.000932	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—UROD—head and neck cancer	9.63e-05	0.000913	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	9.56e-05	0.000907	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—IL2—head and neck cancer	9.48e-05	0.000899	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.43e-05	0.000894	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—NAT2—head and neck cancer	9.34e-05	0.000886	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.32e-05	0.000883	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—RARB—head and neck cancer	8.76e-05	0.00083	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—TYMS—head and neck cancer	8.64e-05	0.000819	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—IL2—head and neck cancer	8.6e-05	0.000816	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.58e-05	0.000813	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—GSTM1—head and neck cancer	8.54e-05	0.00081	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—DPYD—head and neck cancer	8.19e-05	0.000777	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—GPX1—head and neck cancer	8.18e-05	0.000776	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.12e-05	0.00077	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CYP1A1—head and neck cancer	8.09e-05	0.000768	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—YAP1—head and neck cancer	7.97e-05	0.000756	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—YAP1—head and neck cancer	7.77e-05	0.000737	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	7.46e-05	0.000707	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—TYMS—head and neck cancer	7.44e-05	0.000706	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—NAT2—head and neck cancer	7.4e-05	0.000702	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NOTCH1—head and neck cancer	7.39e-05	0.000701	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GSTM1—head and neck cancer	7.36e-05	0.000698	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	7.35e-05	0.000697	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—NAT2—head and neck cancer	7.33e-05	0.000695	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	7.12e-05	0.000675	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GPX1—head and neck cancer	7.05e-05	0.000668	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	7.04e-05	0.000668	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	7.02e-05	0.000666	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CYP1A1—head and neck cancer	6.98e-05	0.000662	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—MAPK3—head and neck cancer	6.92e-05	0.000656	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	6.75e-05	0.00064	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	6.65e-05	0.000631	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.65e-05	0.000631	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—MAPK1—head and neck cancer	6.58e-05	0.000624	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—EGFR—head and neck cancer	6.58e-05	0.000624	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—DPYD—head and neck cancer	6.49e-05	0.000615	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—DPYD—head and neck cancer	6.43e-05	0.00061	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	6.3e-05	0.000598	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—PIK3CA—head and neck cancer	6.29e-05	0.000597	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—YAP1—head and neck cancer	6.16e-05	0.000584	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—YAP1—head and neck cancer	6.1e-05	0.000579	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	5.99e-05	0.000568	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—UROD—head and neck cancer	5.93e-05	0.000563	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.84e-05	0.000554	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.73e-05	0.000544	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PIK3CA—head and neck cancer	5.71e-05	0.000542	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	5.41e-05	0.000513	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NAT2—head and neck cancer	5.3e-05	0.000503	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HRAS—head and neck cancer	5.28e-05	0.000501	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	5.22e-05	0.000495	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—AKT1—head and neck cancer	5.14e-05	0.000487	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.09e-05	0.000483	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL2—head and neck cancer	5.08e-05	0.000482	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCND1—head and neck cancer	4.96e-05	0.00047	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.88e-05	0.000462	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.83e-05	0.000458	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTGS2—head and neck cancer	4.81e-05	0.000457	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PTEN—head and neck cancer	4.78e-05	0.000454	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	4.72e-05	0.000447	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—TYMS—head and neck cancer	4.67e-05	0.000443	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—AKT1—head and neck cancer	4.67e-05	0.000443	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—DPYD—head and neck cancer	4.65e-05	0.000441	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GSTM1—head and neck cancer	4.61e-05	0.000438	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NAT2—head and neck cancer	4.59e-05	0.000435	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	4.46e-05	0.000423	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GPX1—head and neck cancer	4.42e-05	0.000419	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—YAP1—head and neck cancer	4.41e-05	0.000418	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CYP1A1—head and neck cancer	4.37e-05	0.000415	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—VEGFA—head and neck cancer	4.32e-05	0.00041	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—STAT3—head and neck cancer	4.28e-05	0.000406	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.25e-05	0.000403	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.24e-05	0.000403	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTEN—head and neck cancer	4.2e-05	0.000398	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTGS2—head and neck cancer	4.15e-05	0.000393	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MAPK3—head and neck cancer	4.09e-05	0.000388	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—DPYD—head and neck cancer	4.03e-05	0.000382	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NAT2—head and neck cancer	4e-05	0.000379	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MAPK1—head and neck cancer	3.89e-05	0.000369	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EGFR—head and neck cancer	3.89e-05	0.000369	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—YAP1—head and neck cancer	3.82e-05	0.000362	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—TYMS—head and neck cancer	3.7e-05	0.000351	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.68e-05	0.000349	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—TYMS—head and neck cancer	3.66e-05	0.000347	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GSTM1—head and neck cancer	3.65e-05	0.000347	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GSTM1—head and neck cancer	3.62e-05	0.000343	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTEN—head and neck cancer	3.62e-05	0.000343	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.59e-05	0.000341	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—NOTCH1—head and neck cancer	3.59e-05	0.000341	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.56e-05	0.000338	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—DPYD—head and neck cancer	3.51e-05	0.000333	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GPX1—head and neck cancer	3.5e-05	0.000332	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GPX1—head and neck cancer	3.47e-05	0.000329	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP1A1—head and neck cancer	3.46e-05	0.000328	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP1A1—head and neck cancer	3.43e-05	0.000326	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PIK3CA—head and neck cancer	3.37e-05	0.00032	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—YAP1—head and neck cancer	3.33e-05	0.000316	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—head and neck cancer	3.26e-05	0.00031	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HRAS—head and neck cancer	3.12e-05	0.000296	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.01e-05	0.000285	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PIK3CA—head and neck cancer	2.96e-05	0.000281	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.87e-05	0.000272	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AKT1—head and neck cancer	2.76e-05	0.000261	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—TYMS—head and neck cancer	2.65e-05	0.000251	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GSTM1—head and neck cancer	2.62e-05	0.000248	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTGS2—head and neck cancer	2.6e-05	0.000247	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PIK3CA—head and neck cancer	2.55e-05	0.000242	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GPX1—head and neck cancer	2.51e-05	0.000238	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.5e-05	0.000237	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP1A1—head and neck cancer	2.48e-05	0.000235	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NAT2—head and neck cancer	2.46e-05	0.000234	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—AKT1—head and neck cancer	2.42e-05	0.000229	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—TYMS—head and neck cancer	2.29e-05	0.000218	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTEN—head and neck cancer	2.27e-05	0.000215	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTM1—head and neck cancer	2.27e-05	0.000215	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GPX1—head and neck cancer	2.17e-05	0.000206	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—DPYD—head and neck cancer	2.16e-05	0.000205	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP1A1—head and neck cancer	2.15e-05	0.000204	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—AKT1—head and neck cancer	2.08e-05	0.000198	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTGS2—head and neck cancer	2.06e-05	0.000195	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—YAP1—head and neck cancer	2.05e-05	0.000194	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTGS2—head and neck cancer	2.04e-05	0.000194	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—TYMS—head and neck cancer	2e-05	0.00019	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—MAPK3—head and neck cancer	1.99e-05	0.000188	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTM1—head and neck cancer	1.98e-05	0.000187	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GPX1—head and neck cancer	1.89e-05	0.000179	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.87e-05	0.000178	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTEN—head and neck cancer	1.8e-05	0.00017	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTEN—head and neck cancer	1.78e-05	0.000169	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.77e-05	0.000167	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PIK3CA—head and neck cancer	1.6e-05	0.000152	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.48e-05	0.00014	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—AKT1—head and neck cancer	1.34e-05	0.000127	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—AKT1—head and neck cancer	1.31e-05	0.000124	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTEN—head and neck cancer	1.29e-05	0.000122	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.28e-05	0.000121	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PIK3CA—head and neck cancer	1.27e-05	0.00012	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.26e-05	0.000119	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TYMS—head and neck cancer	1.23e-05	0.000117	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.22e-05	0.000115	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GPX1—head and neck cancer	1.17e-05	0.000111	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.15e-05	0.000109	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTEN—head and neck cancer	1.11e-05	0.000106	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTGS2—head and neck cancer	1.11e-05	0.000106	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AKT1—head and neck cancer	1.04e-05	9.82e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AKT1—head and neck cancer	1.03e-05	9.73e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTEN—head and neck cancer	9.71e-06	9.21e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PIK3CA—head and neck cancer	9.08e-06	8.61e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PIK3CA—head and neck cancer	7.86e-06	7.46e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AKT1—head and neck cancer	7.42e-06	7.03e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTGS2—head and neck cancer	6.86e-06	6.51e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PIK3CA—head and neck cancer	6.85e-06	6.5e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AKT1—head and neck cancer	6.42e-06	6.09e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTEN—head and neck cancer	5.98e-06	5.67e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AKT1—head and neck cancer	5.6e-06	5.31e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.22e-06	4e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AKT1—head and neck cancer	3.45e-06	3.27e-05	CbGpPWpGaD
